A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV. - Wikidata - wikimedia - TriplyDB

A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV.

A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV.

http://www.wikidata.org/entity/Q31141618

about

Notch signalling pathway as an oncogenic factor involved in cancer development Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer.Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome.The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials and observational studies.

P2860

Q28072977-12B60540-F4C0-48CF-8369-E7DDFFF0813F Q37017000-5EBB988B-8076-4BA1-9FF5-2C97CB489911 Q38282823-0A4C845F-4EAA-4BFD-BA0B-2D410720057C Q40443819-9DED345D-387A-4A53-B9B6-729DDBA6D07C Q43011510-7D2FF725-85A3-478A-9EA6-70B78CCC2D66 Q55008645-9C1DE832-F422-4183-9782-1C687EDD6402

P2860

A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV.

http://www.wikidata.org/entity/Q31141618

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@ast

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@en

type

label

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@ast

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@en

prefLabel

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@ast

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@en

P1433

Q31141618-64C662AC-2DCD-49B0-8FA0-EA4D48B34E12

P1476

Q31141618-E0524DEA-A8B4-4391-8FEE-E914660845B8

P2093

Q31141618-3B8B6D20-9ED9-4106-A092-CF61B5AEF24B

Q31141618-9D613EA5-EE64-4A7D-9101-E0D6339C3D52

Q31141618-B28C8F06-E34A-45E2-95F4-17C60DC9696C

Q31141618-C6C0341A-47AF-4F4F-B90F-33C851910A90

Q31141618-CDD84AAC-5D8D-40DB-B738-6E8E7233CA73

P2860

Q31141618-2292E4CC-F18E-49D4-82C6-5D5A0CD037BE

Q31141618-32ED2510-6ACE-4258-AB21-E78398A4D04F

Q31141618-4ABD356B-E366-4922-9CD6-65DDD9375AC9

Q31141618-577F5853-F0E8-418E-B9CC-86FEDE8054F3

Q31141618-726C31DF-A967-461E-9EBF-A23497BC6122

Q31141618-8D41DE55-E918-4BCD-A9CA-E274E7873F36

Q31141618-9AE3C02B-BD2A-4D83-9A42-E8D4027F010C

Q31141618-9B092874-FE1B-47DF-8B55-EB4B30AB7C0A

Q31141618-9B48F031-CCCA-412E-B7FA-930241C0AB54

Q31141618-9BCA4C5B-B963-4851-88E2-F54B0CF80757

P2888

Q31141618-47CF9856-BF73-473E-B767-F96E28F458D7

P304

Q31141618-A78BEAC4-8861-4ED7-99B5-EA01EDB74D28

P31

Q31141618-4B94CFE9-6FD9-4867-9356-934741A4B169

Q31141618-c01742a1-6481-4c09-b72b-cf0e8c3d0ceb

P356

Q31141618-98FD8BB0-3575-4F74-902F-8CC42AA8AB6C

P478

Q31141618-CCB28BA1-5CED-4E08-A789-32D3C733FBA8

P577

Q31141618-13AE51EA-22AC-433E-9C55-0224A3ED489B

P5875

Q31141618-4F590184-67D4-4985-BFD5-AF5B34E0B904

P6179

Q31141618-3A812A83-653A-49B0-95C0-E64F4DF04BFE

P698

Q31141618-6340AF7E-A8EF-4172-8022-09AECD0F8693

P921

Q31141618-CB6C65F6-AFEB-4BF7-922A-76FA33184998

P932

Q31141618-64E5300F-70AA-4798-850D-648BEC5A04B1

P356

1477-7819-11-267

P1433

World Journal of Surgical Oncology

P1476

A meta-analysis: neoadjuvant c ...... arcinoma FIGO stageIII and IV.

@en

P2093

Cai Hong-Wei

http://www.w3.org/2001/XMLSchema#string

Li Xian-fu

http://www.w3.org/2001/XMLSchema#string

Ma Dai-yuan

http://www.w3.org/2001/XMLSchema#string

Tan Bang-xian

http://www.w3.org/2001/XMLSchema#string

Zhou Ye-qin

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.

Surgical staging and cytoreductive surgery of epithelial ovarian cancer.

Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.

Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma.

The impact of subspecialty training on the management of advanced ovarian cancer.

P2888

1477-7819-11-267

P304

267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7819-11-267

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257647138

http://www.w3.org/2001/XMLSchema#string

P6179

1014715819

http://www.w3.org/2001/XMLSchema#string

P698

24112995

http://www.w3.org/2001/XMLSchema#string

P921

P932

3852916

http://www.w3.org/2001/XMLSchema#string